A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Insomnia
Interventions
DRUG

zolpidem tartrate sublingual tablet

3.5 milligram zolpidem tartrate sublingual tablet taken as needed following a middle-of-the-night awakening over the 28-night study period. Participants placed the study drug under the tongue and allowed it to dissolve there for about 2 minutes, then swallowed after dissolved.

DRUG

Placebo

Placebo sublingual tablet taken as needed following a middle-of-the-night awakening over the 28-night study period. Participants placed the study drug under the tongue and allowed it to dissolve there for about 2 minutes, then swallowed after dissolved.

Trial Locations (1)

27710

Transcept Investigational Site, Durham

Sponsors
All Listed Sponsors
lead

Transcept Pharmaceuticals

INDUSTRY

NCT00466193 - A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia | Biotech Hunter | Biotech Hunter